Search by Drug Name or NDC
NDC 24201-0207-03 Icatibant 30 mg/3mL Details
Icatibant 30 mg/3mL
Icatibant is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is ICATIBANT ACETATE.
Product Information
| NDC | 24201-0207 |
|---|---|
| Product ID | 24201-207_09ce1cbd-7fed-79d2-e063-6294a90a1db3 |
| Associated GPIs | 85820040102020 |
| GCN Sequence Number | 064564 |
| GCN Sequence Number Description | icatibant acetate SYRINGE 30 MG/3 ML SUBCUT |
| HIC3 | A7M |
| HIC3 Description | BRADYKININ B2 RECEPTOR ANTAGONISTS |
| GCN | 14778 |
| HICL Sequence Number | 035962 |
| HICL Sequence Number Description | ICATIBANT ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Icatibant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | icatibant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/3mL |
| Substance Name | ICATIBANT ACETATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211021 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24201-0207-03 (24201020703)
| NDC Package Code | 24201-207-03 |
|---|---|
| Billing NDC | 24201020703 |
| Package | 3 CARTON in 1 CARTON (24201-207-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2020-03-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |